Income Statement (ALIMERA)

Technical Analysis Historical Data Financials News & Analysis

ALIMERA NEWS

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact By Vandana - 1 week ago

ANI Pharmaceuticals Inc (NASDAQ:ANIP) reported first-quarter adjusted earnings of $1.70 per share on Friday, up from $1.21 a year ago, beating the consensus of $1.38 per share. The company reported … [+2479 chars]...

Read more
Age-Related Macular Degeneration (AMD) Market Forecast Report and Company Analysis 2025-2033 Featuring Hoffmann - La Roche, Bayer, Abbvie, GSK, Novartis, Regeneron Pharma, Bausch, Alimera Science By Research - 1 week ago

Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Age-Related Macular Degeneration (AMD) Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAnd… [+8111 chars]...

Read more
Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database By Site Author - 6 days ago

  • X @GONZAGAGARAYARAMBURU, @doctorpuzo, @DrMAZapata, @@carlos_ciller, @JavierZarranz
  • CollaboratorsFRB SPAIN-IMAGE project investigators (by centre: principal investigator and collaborator… [+3830 chars]...

    Read more
    • Top Stock
    CurrencyPrice Chg
    BA         		200.53 -2.88
    -1.42%
    CVX         		135.19 -0.1
    -0.07%
    CAT         		341.53 -3.67
    -1.06%
    INTC         		20 -0.56
    -2.7%
    MSFT         		450.03 -4.83
    -1.06%
    DIS         		109.57 -1.56
    -1.4%
    DOW         		27.99 -0.68
    -2.37%
    CSCO         		62.63 -0.73
    -1.15%
    GS         		594.53 -3.7
    -0.62%